The Surge in Human Papillomavirus Vaccine Rejection in Nigeria DOI
Oche Joseph Otorkpa, Onifade Adefunmilola Adebola, Chinenye Oche Otorkpa

et al.

Cancer Prevention Research, Journal Year: 2024, Volume and Issue: 17(11), P. 497 - 498

Published: Nov. 1, 2024

Abstract In October 2023, Nigeria integrated the single-dose human papillomavirus (HPV) vaccine into its routine immunization program, aiming to protect 7.7 million girls aged 9 14 years. This milestone in fight against HPV-related cancers, especially cervical cancer, faces significant challenges due high rejection rates driven by misinformation and cultural barriers. Despite vaccine’s proven safety efficacy, uptake remains low. communication highlights urgent need for a comprehensive public health education campaign address these Proposed strategies include leveraging digital technologies, integrating HPV school curricula, training community workers, engaging religious leaders, launching media campaigns featuring personal narratives. Implementing evidence-based interventions is crucial dispelling myths, misconceptions, skepticism surrounding vaccines. will enhance acceptance uptake, ultimately reducing cancer mortality Nigeria.

Language: Английский

Effects of a multimedia campaign to increase human papillomavirus vaccine acceptance in Dhaka, Bangladesh DOI Creative Commons
Sohail Agha, Sarah Francis, Drew Bernard

et al.

Human Vaccines & Immunotherapeutics, Journal Year: 2025, Volume and Issue: 21(1)

Published: Jan. 8, 2025

Increasing the uptake of Human Papillomavirus (HPV) vaccine among adolescent girls is a high priority for government Bangladesh. This study examines correlates HPV adoption in Dhaka Division, largest division The 18-day vaccination campaign was accompanied by multimedia messages. We use Fogg Behavior Model (FBM) as theoretical framework our analysis. Using survey instrument based on FBM, we analyze cross-sectional data collected from 611 caregivers aged 9–17 Dhaka. Survey November and December 2023. Caregivers were recruited via Facebook Instagram ads interviewed through Messenger App. About one-third reported that their child had been vaccinated. conducted bivariate multivariate analyses to assess relationships between caregivers' motivation, ability, exposure child's status. Adjusted odds ratios logistic regression analyses, suggest contributed uptake. Caregivers' motivation get vaccinated (74%) but ability low (20%). Exposure messages dose-response relationship with adoption. However, 48% remained unexposed campaign. discuss challenges government's program likely face identify program-related research questions are important answer success future efforts.

Language: Английский

Citations

1

Building HPV vaccine confidence through codesigned interventions with and for healthcare workers in Nigeria: protocol for a pilot cluster randomised controlled trial DOI Creative Commons
Sibylle Herzig van Wees, Ayobami A. Bakare, Kofoworola O. Akinsola

et al.

BMJ Open, Journal Year: 2025, Volume and Issue: 15(4), P. e098308 - e098308

Published: April 1, 2025

Introduction The human papillomavirus (HPV) vaccine can effectively prevent cervical cancer, yet HPV uptake is particularly low in some low-income settings, due to supply and confidence barriers. has also been found be lacking among healthcare workers countries, including Nigeria. Nigeria a long history of parts the country. rumours concerns have observed throughout country, workers. Interventions that specifically address workers’ are limited, since often assumed this group. aim our pilot cluster randomised control trial (cRCT) evaluate feasibility conducting evaluates codesigned interventions improve acceptability delivering intervention. Methods analysis This 3-arm cRCT, using mixed-methods approach assess design, alongside intervention delivery two states (Jigawa Oyo). We will implement interventions: one with focus on digital delivery, an champion present at health facility. Both compared arm, providing standard information only. Overall, 12 clusters (six Jigawa six Oyo), defined as government primary facilities, 1:1:1 ratio, stratified by state. All within these facilities eligible take part evaluation. outcome interest uptake, measure subsequent given around contamination clusters. assessed through endline worker survey. Intervention quantitative monitoring qualitative interviews Ethics dissemination received approval from State Committee (ref: JGHREC/2023/151), Ministry Health MOH/PH/PHRAT/MN/23/003), Oyo Research Review AD/13/479/362A), University Ibandan College Hospital (UI/UCH Committee) UI/EC/23/308) Swedish National Board (2023-04772-01-471058). Data presented manuscript form submitted relevant conferences for dissemination. Registration details registered ISRCTN—the UK’s Clinical Study Registry, registration number ISRCTN37847119 .

Language: Английский

Citations

0

Varying behavioral differences and correlates of HPV infection among young adolescents in Benue state, Nigeria DOI Creative Commons

Evelyn Erdoo Orya,

Kayode Khalid Bello,

Sidney Sampson

et al.

BMC Public Health, Journal Year: 2024, Volume and Issue: 24(1)

Published: June 7, 2024

Abstract Background Human Papillomavirus (HPV) infection is a significant public health concern globally, especially in low- and middle-income countries. In Africa, including Nigeria, HPV prevalence high, contributing to substantial burden of cervical cancer. Despite challenges, massive vaccination campaigns Africa show promise for preventing cancer cases. Benue State, limited research exists on several aspects knowledge attitudes towards among secondary school students. This study aims bridge this gap by assessing knowledge, prevention practices, willingness uptake vaccination, associated behaviors students the state. Methods The cross-sectional was conducted adolescents aged 10–19 years six schools three local government areas (LGAs) Nigeria. Two-stage sampling used select LGAs schools, with final sample size 591 selected represent both junior senior levels span across senatorial districts Data were collected using self-administered questionnaire covering sociodemographic characteristics, vaccination. Statistical analyses included univariate tests association, significance set at p < 0.05 or 0.001 depending level stringency evidence required. analyzed SPSS version 25. Results Only 35.4% participants males, 86.8% between ages 10 16. 24.7% acknowledged that can be transmitted during sexual intercourse, 36.2% recognized via skin-to-skin contact. 48.1% noted cause Half (50.9%) early debut increases risk acquiring HPV, while only 28.1% as preventive strategy against infection. 35% correctly stated best time vaccine. practice prevention, 14.9% are relationship 10.3% admitted not condoms intercourse. Also, 11.8% have had STIs, 27.2% previously undergone HIV screening. Various bivariate showed some varying behavioral differences correlates young Conclusions provides valuable insights into discussed themes. has unpacked complex relationships could implications researchers policymakers. Moreover, ten actionable policy recommendations prescribed. Several interventions further proposed.

Language: Английский

Citations

1

The Surge in Human Papillomavirus Vaccine Rejection in Nigeria DOI
Oche Joseph Otorkpa, Onifade Adefunmilola Adebola, Chinenye Oche Otorkpa

et al.

Cancer Prevention Research, Journal Year: 2024, Volume and Issue: 17(11), P. 497 - 498

Published: Nov. 1, 2024

Abstract In October 2023, Nigeria integrated the single-dose human papillomavirus (HPV) vaccine into its routine immunization program, aiming to protect 7.7 million girls aged 9 14 years. This milestone in fight against HPV-related cancers, especially cervical cancer, faces significant challenges due high rejection rates driven by misinformation and cultural barriers. Despite vaccine’s proven safety efficacy, uptake remains low. communication highlights urgent need for a comprehensive public health education campaign address these Proposed strategies include leveraging digital technologies, integrating HPV school curricula, training community workers, engaging religious leaders, launching media campaigns featuring personal narratives. Implementing evidence-based interventions is crucial dispelling myths, misconceptions, skepticism surrounding vaccines. will enhance acceptance uptake, ultimately reducing cancer mortality Nigeria.

Language: Английский

Citations

0